Related Experiment Videos
Summary
Cloprednol, a synthetic glucocorticoid, improved asthma control and lung function in children. This study found no long-term side effects and enhanced adrenal axis responsiveness with cloprednol therapy.
Area of Science:
- Pediatric Pulmonology
- Endocrinology
Background:
- Chronic corticosteroid-dependent asthma in children requires effective long-term management.
- Glucocorticoids are a cornerstone therapy, but long-term use can have side effects and impact the hypothalamopituitary adrenal axis.
Purpose of the Study:
- To evaluate the efficacy and safety of cloprednol in children with chronic corticosteroid-dependent asthma.
- To assess the impact of cloprednol on asthma control, lung function, and hypothalamopituitary adrenal axis responsiveness.
Main Methods:
- A 24-month study involving 20 children with corticosteroid-dependent asthma.
- Replacement of alternate-day prednisone with daily 8 am cloprednol doses.
- Assessment of peak expiratory flow rate and fasting 8 am cortisol levels.
Main Results:
- Ten of 17 completers showed better asthma control on cloprednol compared to prednisone.
- Significant improvement in peak expiratory flow rate was observed (P < .001).
- No long-term side effects were reported, and hypothalamopituitary adrenal axis responsiveness improved.
Conclusions:
- Cloprednol is an effective and safe alternative for managing pediatric corticosteroid-dependent asthma.
- Cloprednol therapy can lead to improved asthma control, lung function, and hypothalamopituitary adrenal axis recovery.